Table 3.

Clinical and laboratories findings in patients with COVID-19.

	Variable	No of study	n/N	%
Clinical manifestations	Chest pain	9	128/1,232	10.38
	Dyspnea	9	9/10	90
	Shortness of breath	11	39/45	88.66
	Cough	14	38/49	77.55
	Fever	14	40/51	78.43
	Fatigue	5	5/5	5
	Tachypnea	7	8/21	30.09
	Crackles	7	7/8	87.5
	Diarrhea	3	3/3	100
	Nausea & vomiting	4	5/6	83.33
Signs	Elevated pulse rate	12	195/1,413	13.8
	Elevated temperature	12	32/33	96.96
Comorbidities	Hypertension	15	526/1,424	36.93
	Diabetes	10	279/1,440	19.37
	Obesity	3	11/17	64.7
	Hyperlipidemia	5	5/5	100
	Ischemic disease	4	200–1,431	13.97
	Obstructive sleep apnea	2	10/35	25.57
	COPDa	3	12/222	5.4
	CKDb	3	17/209	8.13
	CAc	3	15/189	7.93
Laboratory findings	elevated NTproBNP	11	26/214	12.2
	High IL-6	5	5/5	100
	High D-dimer	5	6/6	100
	High ferritin	6	6/6	100
	High CRPd	14	14/201	6.96
	High Troponin	18	307/1412	21.74

n, number of patients with any variables; N, the total number of studied patients.

^aCOPD, Chronic obstructive pulmonary disease;

^bCKD, Chronic kidney disease;

^cCA, Copd/Asthma;

^dCRP, C-reactive protein.